GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
82.60
-1.05 (-1.26%)
At close: Nov 11, 2026, 4:00 PM EST
82.51
-0.09 (-0.11%)
After-hours: Nov 11, 2026, 5:48 PM EST
GEHC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,637 | 20,625 | 19,672 | 19,552 | 18,341 | 17,585 | |
Revenue Growth | 6.87% | 4.84% | 0.61% | 6.60% | 4.30% | 2.45% |
Cost of Revenue | 13,137 | 12,378 | 11,467 | 11,630 | 11,162 | 10,411 |
Gross Profit | 8,500 | 8,247 | 8,205 | 7,922 | 7,179 | 7,174 |
Selling, General & Admin | 4,214 | 3,923 | 3,849 | 3,889 | 3,686 | 3,564 |
Research & Development | 1,311 | 1,260 | 1,311 | 1,205 | 1,026 | 816 |
Operating Expenses | 5,525 | 5,183 | 5,160 | 5,094 | 4,712 | 4,380 |
Operating Income | 2,975 | 3,064 | 3,045 | 2,828 | 2,467 | 2,794 |
Interest Expense | -394 | -381 | -463 | -542 | -86 | -40 |
Interest & Investment Income | 38 | 41 | - | 26 | - | 34 |
Earnings From Equity Investments | -2 | 3 | 8 | 11 | 13 | 27 |
Currency Exchange Gain (Loss) | -41 | -59 | -42 | - | - | - |
Other Non Operating Income (Expenses) | 54 | 7 | 34 | 38 | 53 | 60 |
EBT Excluding Unusual Items | 2,630 | 2,675 | 2,582 | 2,361 | 2,447 | 2,875 |
Gain (Loss) on Sale of Investments | - | 97 | - | - | - | - |
Other Unusual Items | 141 | -4 | -1 | - | 65 | - |
Pretax Income | 2,771 | 2,768 | 2,581 | 2,361 | 2,512 | 2,875 |
Income Tax Expense | 561 | 614 | 531 | 743 | 563 | 600 |
Earnings From Continuing Operations | 2,210 | 2,154 | 2,050 | 1,618 | 1,949 | 2,275 |
Earnings From Discontinued Operations | - | - | - | -4 | 18 | 18 |
Net Income to Company | 2,210 | 2,154 | 2,050 | 1,614 | 1,967 | 2,293 |
Minority Interest in Earnings | -57 | -70 | -57 | -229 | -51 | -46 |
Net Income | 2,153 | 2,084 | 1,993 | 1,385 | 1,916 | 2,247 |
Net Income to Common | 2,153 | 2,084 | 1,993 | 1,385 | 1,916 | 2,247 |
Net Income Growth | -2.84% | 4.57% | 43.90% | -27.71% | -14.73% | -83.77% |
Shares Outstanding (Basic) | 454 | 456 | 456 | 455 | 454 | 454 |
Shares Outstanding (Diluted) | 456 | 458 | 459 | 458 | 454 | 454 |
Shares Change | -0.55% | -0.22% | 0.22% | 0.88% | - | - |
EPS (Basic) | 4.74 | 4.57 | 4.37 | 3.04 | 4.22 | 4.95 |
EPS (Diluted) | 4.73 | 4.55 | 4.34 | 3.03 | 4.22 | 4.95 |
EPS Growth | -2.07% | 4.84% | 43.18% | -28.16% | -14.74% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,889 | 1,505 | 1,550 | 1,714 | 1,803 | 1,359 |
Free Cash Flow Per Share | 4.14 | 3.29 | 3.38 | 3.74 | 3.97 | 2.99 |
Dividend Per Share | 0.145 | 0.140 | 0.125 | 0.120 | - | - |
Dividend Growth | 3.57% | 12.00% | 4.17% | - | - | - |
Gross Margin | 39.28% | 39.98% | 41.71% | 40.52% | 39.14% | 40.80% |
Operating Margin | 13.75% | 14.86% | 15.48% | 14.46% | 13.45% | 15.89% |
Profit Margin | 9.95% | 10.10% | 10.13% | 7.08% | 10.45% | 12.78% |
Free Cash Flow Margin | 8.73% | 7.30% | 7.88% | 8.77% | 9.83% | 7.73% |
EBITDA | 3,597 | 3,642 | 3,625 | 3,438 | 3,100 | 3,419 |
EBITDA Margin | 16.62% | 17.66% | 18.43% | 17.58% | 16.90% | 19.44% |
D&A For EBITDA | 622 | 578 | 580 | 610 | 633 | 625 |
EBIT | 2,975 | 3,064 | 3,045 | 2,828 | 2,467 | 2,794 |
EBIT Margin | 13.75% | 14.86% | 15.48% | 14.46% | 13.45% | 15.89% |
Effective Tax Rate | 20.24% | 22.18% | 20.57% | 31.47% | 22.41% | 20.87% |
Revenue as Reported | 21,637 | 20,625 | 19,672 | 19,552 | 18,341 | 17,585 |